Cargando…

Targeting IL-5 in COPD

Many patients with chronic obstructive pulmonary disease (COPD) continue to experience exacerbations despite receiving standard-of-care treatments. Novel approaches to COPD treatment focus on understanding and targeting molecular mechanisms of airway inflammation, airway obstruction, remodeling and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narendra, Dharani K, Hanania, Nicola A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6529620/ https://www.ncbi.nlm.nih.gov/pubmed/31190789 http://dx.doi.org/10.2147/COPD.S155306

Ejemplares similares

Optimizing safety of COPD treatments: role of the nurse practitioner
por: Spencer, Pamela, et al.
Publicado: (2013)

The role of combination therapy with corticosteroids and long-acting β(2)-agonists in the prevention of exacerbations in COPD
por: Cazzola, Mario, et al.
Publicado: (2006)

Novel Anti-Inflammatory Approaches to COPD
por: Cazzola, Mario, et al.
Publicado: (2023)

Pharmacotherapies in Older Adults with COPD: Challenges and Opportunities
por: Matera, Maria Gabriella, et al.
Publicado: (2023)

Budesonide/formoterol combination in COPD: a US perspective
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer?
por: Adrish, Muhammad, et al.
Publicado: (2023)

Treating COPD Patients with Inhaled Medications in the Era of COVID-19 and Beyond: Options and Rationales for Patients at Home
por: Ari, Arzu, et al.
Publicado: (2021)

The Saudi guidelines for chronic obstructive pulmonary disease: A fresh “Real-World” approach to COPD
por: Hanania, Nicola A.
Publicado: (2014)

RISK FACTORS FOR COVID-19 CRITICAL ILLNESS AMONG TWO URBAN PUBLIC HOSPITALS
por: GRAZIANI, CASEY, et al.
Publicado: (2022)

A review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challenges
por: Cazzola, Mario, et al.
Publicado: (2015)

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
por: D’Urzo, Anthony D, et al.
Publicado: (2018)

Anti-IL5/IL5R Treatment in COPD: Should We Target Oral Corticosteroid-Dependent Patients?
por: Laroche, Jérémy, et al.
Publicado: (2023)

Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD
por: Hanania, Nicola A, et al.
Publicado: (2018)

Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial
por: Hanania, Nicola A, et al.
Publicado: (2011)

Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
por: Drick, Nora, et al.
Publicado: (2022)

IL-26 in the Lung and Its Role in COPD Inflammation
por: Bartziokas, Konstantinos, et al.
Publicado: (2022)

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA
por: Hanania, Nicola A, et al.
Publicado: (2023)

Current and future developments in the pharmacology of asthma and COPD: ERS seminar, Naples 2022
por: Stolz, Daiana, et al.
Publicado: (2023)

Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care
por: Drexel, Carole, et al.
Publicado: (2011)

Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD
por: Strollo, Hilary C, et al.
Publicado: (2021)

Examining fatigue in COPD: development, validity and reliability of a modified version of FACIT-F scale
por: Al-shair, Khaled, et al.
Publicado: (2012)

Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions
por: Hanania, Nicola A, et al.
Publicado: (2019)

Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD
por: Hanania, Nicola A., et al.
Publicado: (2020)

One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD
por: Donohue, James F., et al.
Publicado: (2014)

The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy
por: Riera-Martínez, Lluc, et al.
Publicado: (2023)

Treating severe asthma: Targeting the IL‐5 pathway
por: Principe, Stefania, et al.
Publicado: (2021)

Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population
por: Sharafkhaneh, Amir, et al.
Publicado: (2010)

Targeting HDAC Complexes in Asthma and COPD
por: Zwinderman, Martijn R. H., et al.
Publicado: (2019)

Pathological Mechanism and Targeted Drugs of COPD
por: Guo, Peng, et al.
Publicado: (2022)

ENDEMIC IN THE PANDEMIC: MURINE TYPHUS MASKING AS COVID-19 PNEUMONIA WITH PROFOUND HYPOXEMIA
por: LAVERE, PHILIP, et al.
Publicado: (2021)

Improvement in Lung Function and Patient-Reported Outcomes in Patients with COPD with Comorbid Anxiety and Depression Receiving Nebulized Glycopyrrolate in the GOLDEN 3 and 4 Studies
por: Hanania, Nicola A, et al.
Publicado: (2021)

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial
por: Donohue, James F, et al.
Publicado: (2018)

Endometrial Stem Cell Markers: Current Concepts and Unresolved Questions
por: Tempest, Nicola, et al.
Publicado: (2018)

Health literacy in COPD
por: Roberts, Nicola J, et al.
Publicado: (2008)

Ten years of tiotropium: clinical impact and patient perspectives
por: Yohannes, Abebaw M, et al.
Publicado: (2013)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Identification of Novel Therapeutic Targets in COPD
por: Mortaz, Esmaeil, et al.
Publicado: (2011)

Biological targets for therapeutic interventions in COPD: clinical potential
por: Pelaia, Girolamo, et al.
Publicado: (2006)

A Simplified Score to Quantify Comorbidity in COPD
por: Putcha, Nirupama, et al.
Publicado: (2014)

Therapeutic potential of targeting IL-17 and IL-23 in sepsis
por: Bosmann, Markus, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1s6tn5flnf9m8pl21b2blni5so